James A Geraghty

DOI:https://doi.org/10.5912/jcb43


Abstract:

This paper looks at the challenges, opportunities and strategies involved in building a global biotechnology company. There is no single global strategy that will answer all companies' needs; instead strategies will be dictated by the individual business development plans of a company, its products and its values.

Keywords:global ,international ,strategy ,en ,